US Coverage
Law360 | The Practice of Law
State Specific Coverage
Law360 Authority | Deep News & Analysis
Purdue Pharma L.P.
Case Number:
7:19-bk-23649
Court:
Nature of Suit:
Firms
- Phillips Lytle
- Brown & Connery
- Tarter Krinsky
- Teitelbaum Law Group
- Duane Morris
- Hagens Berman
- Simmons Hanly
- Motley Rice
- Debevoise & Plimpton
- Bielli & Klauder
- Godfrey & Kahn
- Himes Petrarca
- Manatt Phelps
- Wachtell Lipton
- Hurwitz Fine
- Morris Nichols
- Kobre & Kim
- Gilbert LLP
- Seyfarth Shaw
- BatesCarey
- Lowe Stein
- Reed Smith
- Skadden Arps
- O'Melveny & Myers
- Pillsbury Winthrop
- Brown Rudnick
- Foley & Lardner
- Archer & Greiner
- WilmerHale
- Ice Miller
- Barclay Damon
- Arnold & Porter
- Katsky Korins
- Gage Spencer & Fleming
- Pashman Stein
- Hogan Lovells
- Katten Muchin
- Morrison & Foerster
- Doshi Legal Group
- Willkie Farr
- Buchalter LLP
- Terrell Hogan
- Goodwin Procter
- Davis Polk
- ArentFox Schiff
- Crowell & Moring
- McDermott Will & Schulte
- Gertz & Rosen
- Consovoy McCarthy
- Porteous Hainkel
- Rothstein Mandell
- Caplin & Drysdale
- Jones Day
- Porter Hedges
- Kirkland & Ellis
- Bentley & Bruning
- ASK LLP
- Dentons
- Faegre Drinker
- Joseph Hage
- Doster Ullom
- Marino Tortorella
- White & Case
- Boies Schiller
- HSF Kramer
- Spangenberg Shibley
- Cuneo Gilbert
- MoloLamken
- Morgan Lewis
- Blitman & King
- Latham & Watkins
- Akin Gump
- McElroy Deutsch
- Jenner & Block
- Alston & Bird
- Stevens & Lee
- Mintz Levin
- WestLoop Law
- FBT Gibbons
- King & Spalding
- Troutman
- Miller Nash LLP
- Cronin Fried
- Loeb & Loeb
- Diamond McCarthy
- Slevin & Hart
- Plevin & Turner
- Schenck Price
- Bialson Bergen
- Martin S. Rapaport
- Akerman LLP
- Fox Swibel
- Lerner Arnold
- Burke Warren
- Shook Hardy
- Sherrard Roe
- Taft Stettinius
- Sahn Ward
- Cleary Gottlieb
- Simpson Thacher & Bartlett
- Napoli Shkolnik
- D. Miller & Associates
- McGrail & Bensinger
- Marcus & Shapira
- Quinn Emanuel
- Pachulski Stang
- UB Greensfelder
- Wilk Auslander
- Shafferman & Feldman
- Squire Patton
- Hughes Socol
- Robins Kaplan
- Blank Rome
- Keller Rohrback
- Ballard Spahr
- Keller Postman
- Webb Law Firm
- Kleinberg Kaplan
- Clifford Law Offices
- Barack Ferrazzano
- Stutzman Bromberg
- Levenfeld Pearlstein
- MacElree Harvey
- Klehr Harrison
- Pullman & Comley
- Mehri & Skalet
- Tate Law Group LLC
- Lowey Dannenberg
- Williams Mullen
- Waldrep Wall
- Dechert LLP
- Ifrah Law
- Seward & Kissel
- Calfee Halter
- White Coleman & Associates
- Miller Shah
- Susman Godfrey
- O'Brien Belland
- Binder & Schwartz
- Carter Ledyard
- Shipman & Goodwin
- Henrichsen Law Group
- Haug Partners
- Hobbs Straus
- Mayer Brown
- Milbank LLP
Companies
- Teamsters Local 456
- Henry Schein Inc.
- Bristol-Myers Squibb Co.
- Hikma Pharmaceuticals PLC
- Giant Eagle Inc.
- McKesson Corp.
- BDO LLP
- Otis Worldwide Corp.
- Liberty Mutual Insurance Group
- Kodiak Area Native Association
- Ranbaxy
- PRA Health Sciences Inc.
- Ascent Pharmaceuticals Inc.
- Verita Global LLC
- FTI Consulting Inc.
- The Cigna Group
- Aleutian Pribilof Islands Association Inc.
- KVK Tech Inc.
- Collegium Pharmaceutical Inc.
- Noramco Inc.
- Johnson & Johnson
- Cencora Inc.
- Endo International PLC
- Impax Laboratories, Inc.
- Omnicare Inc.
- Bausch Health Cos. Inc.
- Province LLC
- Blue Cross Blue Shield Association
- Oracle Corp.
- Walmart Inc.
- AlixPartners LLP
- Sandoz International GmbH
- Avrio Health LP
- Nardello & Co. LLC
- DuPont de Nemours Inc.
- Hain Capital Group LLC
- United Parcel Service Inc.
- Express Scripts Holding Co.
- CVS Health Corp.
- Ironshore Inc.
- Amneal Pharmaceuticals Inc.
- Sun Pharmaceutical Industries Ltd.
- Loblaw Cos.
- Tucson Medical Center
- TR Capital Management LLC
- Viatris Inc.
- Alaska Native Tribal Health Consortium
- Anda Inc.
- AXA XL Ltd.
- Allergan PLC
- BDO USA LLP
- Rubris Inc.
- Purdue Pharma LP
- United Food & Commercial Workers International Union
- ASM Capital LP
- SAP AG
- Apria Healthcare Group
- Cardinal Health Inc.
- Arcadia Consumer Healthcare
- International Union Of Operating Engineers
- Old Republic Insurance Co.
- Thermo Fisher Scientific Inc.
- Houlihan Lokey Inc.
- American Federation of Labor & Congress of Industrial Organizations
- Jefferies Financial Group Inc.
- Teva Pharmaceutical Industries Ltd.
Government Agencies
- Pension Benefit Guaranty Corp.
- Missouri Department of Revenue
- U.S. District Court for the District of Columbia
- Tennessee Attorney General's Office
- Pala Band of Mission Indians
- Seldovia Village Tribe
- Nez Perce Tribe
- Town of Ramapo, New York
- Jamestown S'Klallam Tribe
- St. Regis Mohawk Tribe
- State of Indiana
- City of Bayonne, New Jersey
- Washington State Department of Revenue
- Colorado Attorney General's Office
- Port Gamble S'Klallam Tribe
- Borough of Paramus, New Jersey
- State of Nevada
- Northwestern Band of the Shoshone Nation
- Town of Babylon, New York
- Town of Brookhaven, New York
- New York Department of Financial Services
- Town of Hempstead, New York
- Commonwealth of Massachusetts
- Hopi Tribe
- Suquamish Tribe
- Ohio Attorney General's Office
Sectors & Industries:
-
December 18, 2025
Purdue Mediator Says Failure Was Not An Option, Part 2
Former bankruptcy Judge Shelley C. Chapman mediated a $7.4 billion settlement in the Chapter 11 case of Purdue Pharma that received court approval last month. She spoke with Law360 about the pressure she faced to reach a deal and the 18-hour mediation sessions that came with renewed negotiations after the U.S. Supreme Court threw out a critical element of the agreement. She also discussed the role of nonmonetary relief for creditors, including the removal of the Sackler name from buildings and institutions.
-
December 17, 2025
Purdue Ch. 11 Mediator Says Settlement Took A Village, Part 1
Former U.S. Bankruptcy Judge Shelley C. Chapman oversaw the most complex mediation she has seen to date as she guided settlement negotiations in the Chapter 11 case of OxyContin maker Purdue Pharma, and those efforts resulted in a $7.4 billion deal confirmed by a New York court last month.
-
November 24, 2025
Judge Explains OK For Purdue Ch. 11, Yellow Plan Confirmed
A judge provided his reasons for approving Purdue's revised Chapter 11 plan, and Yellow Corp. and business internet service provider Everstream Solutions both obtained confirmation for their bankruptcy plans.
-
November 18, 2025
Purdue's $7.4B Ch. 11 Plan Jibes With New Release Paradigm
A New York bankruptcy judge gave a bench ruling Tuesday explaining his decision to confirm Purdue's $7.4 billion Chapter 11 plan, which transforms the pharmaceutical giant into a public benefit company, ruling that liability releases fully comply with new restrictions imposed by the U.S. Supreme Court last year.
-
November 17, 2025
Purdue, Sunnova Score Approvals For Ch. 11 Plans
Purdue Pharma secured a judge's approval of its new bankruptcy plan. The U.S. Supreme Court won't review a ruling regarding the Serta Simmons Chapter 11 plan. And solar panel company Sunnova also got a court's permission to implement a bankruptcy plan.
-
November 14, 2025
Purdue's $7.4B Ch. 11 Plan To Be Confirmed
A New York bankruptcy judge agreed to confirm the $7.4 billion Chapter 11 plan of Purdue Pharma LP on Friday, saying he would issue a formal bench ruling next Tuesday explaining his decision.
-
November 13, 2025
Objecting Claimants Have Their Say On Purdue Ch. 11 Plan
A New York bankruptcy judge heard statements from more than a dozen opioid personal injury claimants objecting to the Chapter 11 plan of OxyContin maker Purdue Pharma Thursday as the pro se objectors shared concerns about their recoveries, the lack of criminal prosecution of the company's owners and faults in the system that allowed the opioid crisis to occur in the first place.
-
November 12, 2025
Purdue Kicks Off Ch. 11 Confirmation With Plan Overview
Bankrupt OxyContin maker Purdue Pharma began its Chapter 11 confirmation trial Wednesday with an overview of its latest plan and the myriad settlements that underpin the proposal, including a $6.5 billion commitment from the company's owners.
-
November 07, 2025
Purdue Expects Smooth Confirmation Of New $7.5B Plan
Bankrupt drugmaker Purdue Pharma will begin a confirmation trial for its latest Chapter 11 plan Wednesday in a vastly different position than the last time it came to court seeking similar relief in 2021, when a New York judge approved a plan — over the objections of key parties — that was later struck down by the U.S. Supreme Court.
-
November 07, 2025
What's Happening In Bankruptcy Court This Coming Week
It's a confirmation-seeking bonanza in the coming week as the Archdiocese of New Orleans will come to court for a pretrial conference related to its bankruptcy plan, Purdue will seek confirmation of its Chapter 11 plan, and Yellow Corp. will make its own bid for plan approval.